Claudia Bracaglia

Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis

Jurgen Sota, Antonella Insalaco, Rolando Cimaz et al. · Frontiers in Pharmacology · 2019 · 616 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +13

Elevated circulating levels of interferon-γ and interferon-γ-induced chemokines characterise patients with macrophage activation syndrome complicating systemic juvenile idiopathic arthritis

Claudia Bracaglia, Kathy de Graaf, Denise Pires Marafon et al. · Annals of the Rheumatic Diseases · 2016 · 291 citations

Medicine, Immunology, Pathology +17

Inhibition of Natural Killer Cell Cytotoxicity by Interleukin‐6: Implications for the Pathogenesis of Macrophage Activation Syndrome

Loredana Cifaldi, Giusi Prencipe, Ivan Caiello et al. · Arthritis & Rheumatology · 2015 · 269 citations

Life Sciences, Immunology, Pathobiology +17

EULAR/PRINTO/PRES criteria for Henoch-Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part I: Overall methodology and clinical characterisation

Nicolino Ruperto, Seza Özen, Angela Pistorio et al. · Annals of the Rheumatic Diseases · 2010 · 239 citations

Medicine, Pathology, Pediatrics +13

Prednisone versus prednisone plus ciclosporin versus prednisone plus methotrexate in new-onset juvenile dermatomyositis: a randomised trial

Nicolino Ruperto, Angela Pistorio, Sheila Oliveira et al. · The Lancet · 2015 · 232 citations

Medicine, Dermatology, Pediatrics +15